| Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects M Ingelman-Sundberg, SC Sim, A Gomez, C Rodriguez-Antona Pharmacology & therapeutics 116 (3), 496-526, 2007 | 1477 | 2007 |
| Cytochrome P450 pharmacogenetics and cancer C Rodriguez-Antona, M Ingelman-Sundberg Oncogene 25 (11), 1679-1691, 2006 | 697 | 2006 |
| Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma I Comino-Méndez, FJ Gracia-Aznárez, F Schiavi, I Landa, ... Nature genetics 43 (7), 663-667, 2011 | 582 | 2011 |
| Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells C Rodríguez-Antona, MT Donato, A Boobis, RJ Edwards, PS Watts, ... Xenobiotica 32 (6), 505-520, 2002 | 465 | 2002 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 392 | 2017 |
| Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes LJ Leandro‐García, S Leskelä, I Landa, C Montero‐Conde, ... Cytoskeleton 67 (4), 214-223, 2010 | 309 | 2010 |
| Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre … J Garcia-Donas, E Esteban, LJ Leandro-García, DE Castellano, ... The lancet oncology 12 (12), 1143-1150, 2011 | 289 | 2011 |
| Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene A Cascón, I Comino-Méndez, M Currás-Freixes, AA de Cubas, ... Journal of the National Cancer Institute 107 (5), djv053, 2015 | 240 | 2015 |
| The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients S Leskelä, LJ Leandro-García, M Mendiola, J Barriuso, L Inglada-Pérez, ... Endocrine-related cancer 18 (1), 85-95, 2011 | 235 | 2011 |
| Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas E López-Jiménez, G Gómez-López, LJ Leandro-García, I Muñoz, ... Molecular endocrinology 24 (12), 2382-2391, 2010 | 221 | 2010 |
| Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy M Ingelman-Sundberg, C Rodriguez-Antona Philosophical Transactions of the Royal Society B: Biological Sciences 360 …, 2005 | 200 | 2005 |
| The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors I Landa, S Ruiz-Llorente, C Montero-Conde, L Inglada-Pérez, F Schiavi, ... PLoS genetics 5 (9), e1000637, 2009 | 196 | 2009 |
| Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis I Comino-Méndez, AA de Cubas, C Bernal, C Álvarez-Escolá, ... Human molecular genetics 22 (11), 2169-2176, 2013 | 178 | 2013 |
| Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity C Rodríguez-Antona, MT Donato, E Pareja, MJ Gómez-Lechón, ... Archives of biochemistry and biophysics 393 (2), 308-315, 2001 | 175 | 2001 |
| Genetics of pheochromocytoma and paraganglioma in Spanish patients A Cascon, G Pita, N Burnichon, I Landa, E Lopez-Jiménez, ... The Journal of Clinical Endocrinology & Metabolism 94 (5), 1701-1705, 2009 | 166 | 2009 |
| Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity S Leskelä, C Jara, LJ Leandro-Garcia, A Martinez, J Garcia-Donas, ... The pharmacogenomics journal 11 (2), 121-129, 2011 | 161 | 2011 |
| Phenotype–genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles C Rodríguez-Antona, JG Sayi, LL Gustafsson, L Bertilsson, ... Biochemical and biophysical research communications 338 (1), 299-305, 2005 | 144 | 2005 |
| Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1 M Karlgren, A Gomez, K Stark, J Svärd, C Rodriguez-Antona, E Oliw, ... Biochemical and biophysical research communications 341 (2), 451-458, 2006 | 143 | 2006 |
| Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis C Rodríguez-Antona, J Pallares, C Montero-Conde, L Inglada-Pérez, ... Endocrine-Related Cancer 17 (1), 7-16, 2010 | 142 | 2010 |
| Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment C Rodriguez-Antona, A Gomez, M Karlgren, SC Sim, ... Human genetics 127, 1-17, 2010 | 138 | 2010 |
